Rosenblatt Reiterates Buy Rating on Quantinuum Inc.

Rosenblatt maintains its Buy rating on Quantinuum Inc. with a $155 target, a 89.63% upside from the current price.

Key Points

  • Rosenblatt reiterated its Buy rating on Quantinuum Inc. (QNT) with a $155 price target as of June 29, 2026.
  • Rosenblatt's $155 price target implies 89.63% upside from Quantinuum Inc.'s ($QNT) current $81.74 share price.
  • Shares of NasdaqGM:QNT traded near $81.74 on Wednesday, with a market cap of approximately $21.19 billion.
  • Insiders, including CFO Nitesh Sharan, bought shares on June 5, 2026, at an average price of $60 each.

Important disclosure: Podchat is not a registered investment adviser, broker-dealer, or financial planner. This article is for informational and educational purposes only and is not a recommendation to buy, sell, or hold any security. Content may be generated by automated systems using public filings, market data, and third-party sources, and may contain errors or omissions. Investing involves risk, including possible loss of principal. Past performance, insider activity, analyst ratings, price targets, sentiment scores, and hypothetical or backtested results are not guarantees of future performance. Please do your own research and consult a qualified professional before making investment decisions.

Rosenblatt reiterated its Buy rating on Quantinuum Inc. (NasdaqGM:QNT) with a price target of $155. This reaffirmation came from analyst John McPeake on June 29, 2026, reflecting continued confidence in the company's potential.

Analyst rating track record

Rosenblatt vs. the S&P 500

YTD return +41.40% hypothetical
All-time return +88.28% S&P 500 +27.15%
vs. S&P 500 +61.13% ahead of the index

Hypothetical, simulated performance of disclosed positions vs. the S&P 500. Not realized profit and not investment advice. Past performance does not indicate future results. Details.

Quantinuum Inc. Stock Up 63.7%

Shares of Quantinuum Inc. traded near $81.74 on Wednesday. The company has a market capitalization of about $21.19 billion. Despite not being profitable, Quantinuum's forward P/E ratio is negative at -52.22. The stock's 52-week range spans from $50.10 to $82.30, with a 50-day moving average of $63.29 and the same for the 200-day moving average. The company has a strong current ratio of 11.04 and a quick ratio of 10.66, with a debt-to-equity ratio of 1.61.

12-month forecast

$QNT price target

Past daily closes and this analyst's 12-month price target. Not investment advice.

Insider Buying and Selling at Quantinuum Inc.

On June 5, 2026, several insiders at Quantinuum Inc. purchased shares at an average price of $60 each. CFO Nitesh Sharan acquired 6,500 shares, while other insiders like Michal Stepniak, Joseph Jimenez, Vimal Kapur, Eric Branderiz, and Prineha Narang also made significant purchases. These transactions were not part of any pre-arranged trading plans.

Analysts Set New Price Targets

On June 29, 2026, several firms set new price targets for Quantinuum Inc. Morgan Stanley initiated coverage with a Hold rating and a $78 target. UBS, JP Morgan, Jefferies, Cantor Fitzgerald, and Mizuho all initiated coverage with Buy ratings, setting price targets between $90 and $100. Craig-Hallum was the most optimistic, setting a target at $100. Rosenblatt's reiterated Buy rating comes with the highest target at $155.

About Quantinuum Inc.

Quantinuum Inc. is a leading player in the quantum computing field, developing both hardware and software solutions. Based in Broomfield, Colorado, the company was founded in 2021 and is helmed by CEO Nitesh Sharan. Quantinuum's offerings include quantum hardware platforms, developer tools, and application libraries, designed to bring quantum computing to practical applications globally.

Bottom Line

Rosenblatt's continued Buy rating and high price target on Quantinuum Inc. indicate strong confidence in its future prospects. Investors keep a close eye on such analyst ratings as they offer insights into potential stock performance. However, it's important to remember that these ratings reflect past analysis and may not represent current conditions.

Get Quantinuum Inc. alerts

New 13F filings, insider trades, and analyst moves on $QNT, sent to your inbox. Free, and you can unsubscribe anytime.

This instant news alert was generated by automated narrative technology and financial data from Podchat and public regulatory filings. It is for informational purposes only and is not financial advice.